The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: a Survey Based Experiment

Providing evidence about the benefits and safety of psilocybin increases public support for psilocybin-related policies. In an online experiment with 804 participants, those who received information about psilocybin's benefits showed greater overall policy support and stronger beliefs that psilocybin is both beneficial and safe. Those who received safety information also showed greater policy support and stronger beliefs about safety, but not about benefits. The effects were small (Cohen's d between 0.10 and 0.44). The authors suggest that communicating benefits and safety can shape attitudes, but note that further research is needed on how long these effects last.

Study at a glance

Abstract

BACKGROUND: Preliminary evidence suggests psilocybin may have therapeutic value for various mental health conditions; despite this, it is currently illegal in the UK. Less is known about how people form their attitudes towards psilocybin policies. OBJECTIVES: To explore whether beliefs about the benefits and safety of psilocybin influence support for psilocybin policies. METHODS: In an online survey experiment, 804 participants were randomised to receive one of four interventions in a 2 (no information vs evidence for psilocybin benefits) x 2 (no information vs evidence for psilocybin safety) design. Public support for four psilocybin policies and beliefs about the benefits and safety of psilocybin were measured before and after participants were randomised to a group. RESULTS: In a two-way ANCOVA, the Benefits Intervention significantly increased policy support overall (d = 0.11, p < .001); and for two of four psilocybin policies when analysed separately. Furthermore, the Benefits Intervention significantly strengthened beliefs that psilocybin is beneficial (d = 0.44, p < .001) and safe (d = 0.26, p < .001). The Safety Intervention increased psilocybin policy support overall (d = 0.10, p = .003); and for three of four psilocybin policies when analysed separately. The Safety Intervention also strengthened beliefs that psilocybin is safe (d = 0.28, p < .001) but not that it is beneficial. CONCLUSIONS: Communicating the benefits and safety of psilocybin can increase psilocybin policy support and strengthen beliefs about psilocybin, however further research is needed to explore the longevity of these results.